Protection of IFNAR (-/-) mice against bluetongue virus serotype 8, by heterologous (DNA/rMVA) and homologous (rMVA/rMVA) vaccination, expressing outer-capsid protein VP2
about
Protective Efficacy in Sheep of Adenovirus-Vectored Vaccines against Bluetongue Virus Is Associated with Specific T Cell ResponsesInterferons and their receptors in birds: a comparison of gene structure, phylogenetic analysis, and cross modulationCurrent and next-generation bluetongue vaccines: Requirements, strategies, and prospects for different field situations.Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against bluetongue virus serotype 8 in cattleExpression of VP7, a Bluetongue virus group specific antigen by viral vectors: analysis of the induced immune responses and evaluation of protective potential in sheepNs1 is a key protein in the vaccine composition to protect Ifnar(-/-) mice against infection with multiple serotypes of African horse sickness virus.Purification, stability, and immunogenicity analyses of five bluetongue virus proteins for use in development of a subunit vaccine that allows differentiation of infected from vaccinated animals.Ovine and murine T cell epitopes from the non-structural protein 1 (NS1) of bluetongue virus serotype 8 (BTV-8) are shared among viral serotypes.Vesicular stomatitis virus replicon expressing the VP2 outer capsid protein of bluetongue virus serotype 8 induces complete protection of sheep against challenge infection.DNA vaccine prime and recombinant FPV vaccine boost: an important candidate immunization strategy to control bluetongue virus type 1.
P2860
Q27340815-3CBF2392-3959-4CA7-9F3E-DE8AC9F3D348Q28649915-38FA69AE-3C97-40F5-A31C-623023F3FB63Q30242080-3C70D2E9-CA65-4FF0-B5C2-6AEC0B053784Q34347583-9F1F67C9-2262-4BFF-A87D-2A2FE7D9E8E7Q34445566-E04ACA53-E5F0-4CBE-87B2-71C11AEA3197Q34875697-26CD691B-2937-4E28-A44C-5803A684D397Q37643307-5F006D46-3975-4E94-8CA8-8646ED097F08Q37716789-ABA5C9E8-391E-4151-8D07-3345AE4EA389Q39142927-720D8CD6-16D2-4ACB-9E2F-6A9A6CD3E9C6Q40864230-34616416-4264-4670-8002-4EAD38A24829
P2860
Protection of IFNAR (-/-) mice against bluetongue virus serotype 8, by heterologous (DNA/rMVA) and homologous (rMVA/rMVA) vaccination, expressing outer-capsid protein VP2
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Protection of IFNAR (-/-) mice ...... ssing outer-capsid protein VP2
@ast
Protection of IFNAR (-/-) mice ...... ssing outer-capsid protein VP2
@en
Protection of IFNAR (-/-) mice ...... ssing outer-capsid protein VP2
@nl
type
label
Protection of IFNAR (-/-) mice ...... ssing outer-capsid protein VP2
@ast
Protection of IFNAR (-/-) mice ...... ssing outer-capsid protein VP2
@en
Protection of IFNAR (-/-) mice ...... ssing outer-capsid protein VP2
@nl
prefLabel
Protection of IFNAR (-/-) mice ...... ssing outer-capsid protein VP2
@ast
Protection of IFNAR (-/-) mice ...... ssing outer-capsid protein VP2
@en
Protection of IFNAR (-/-) mice ...... ssing outer-capsid protein VP2
@nl
P2093
P2860
P1433
P1476
Protection of IFNAR (-/-) mice ...... ssing outer-capsid protein VP2
@en
P2093
Abdelghani Bin-Tarif
Eva Calvo-Pinilla
Francisco Mateos
Haru-Hisa Takamatsu
Javier Castillo-Olivares
Javier Ortego
Katarzyna Bachanek-Bankowska
Peter Paul Clement Mertens
Simon Gubbins
P2860
P304
P356
10.1371/JOURNAL.PONE.0060574
P407
P577
2013-04-12T00:00:00Z